Evaluation of human nasal RPMI 2650 cells grown at an air–liquid interface as a model for nasal drug transport studies
- 1 March 2008
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 97 (3) , 1165-1178
- https://doi.org/10.1002/jps.21031
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Needle-free vaccine delivery☆Advanced Drug Delivery Reviews, 2006
- Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectivesAdvanced Drug Delivery Reviews, 2005
- Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cellsEuropean Journal of Pharmaceutical Sciences, 2005
- Pulmonary Delivery of Low Molecular Weight HeparinsPharmaceutical Research, 2004
- Cyclodextrins in Nasal Delivery of Low-Molecular-Weight Heparins: In Vivo and in Vitro StudiesPharmaceutical Research, 2004
- Nasal drug delivery—possibilities, problems and solutionsJournal of Controlled Release, 2002
- The biopharmaceutical aspects of nasal mucoadhesive drug deliveryJournal of Pharmacy and Pharmacology, 2001
- Characterization of the Calu-3 cell line as a tool to screen pulmonary drug deliveryInternational Journal of Pharmaceutics, 2000
- In vitro cell models to study nasal mucosal permeability and metabolismAdvanced Drug Delivery Reviews, 1998
- The Use of Cultured Epithelial and Endothelial Cells for Drug Transport and Metabolism StudiesPharmaceutical Research, 1990